A research team coordinated from the Universitat Autònoma de Barcelona (UAB), with the participation of Judit Ribas, lecturer at the University of Lleida and head of the IRBLleida Pharmacology Unit research group, describes how a substance called gossypol primes glioblastoma cells, an incurable type of …